69.00
+0.50
+(0.73%)
At close: January 10 at 5:35:48 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
117,326.00
33,623.00
33,226.00
12,611.00
12,985.00
Investing Cash Flow
8,050.00
42,303.00
1,689.00
24,857.00
75,446.00
Financing Cash Flow
-189,632.00
-211,266.00
-46,133.00
-27,247.00
-11,884.00
End Cash Position
54,460.00
50,275.00
185,825.00
198,560.00
185,937.00
Capital Expenditure
-19,454.00
-15,311.00
-7,310.00
-8,504.00
-8,085.00
Issuance of Capital Stock
2,448.00
687.00
270.00
761.00
5,251.00
Repayment of Debt
--
-176,028.00
-916.00
-2,624.00
-1,788.00
Repurchase of Capital Stock
-3,891.00
-12,475.00
-24,747.00
-20,506.00
-5,721.00
Free Cash Flow
97,872.00
18,312.00
25,916.00
4,107.00
4,900.00
12/31/2020 - 1/2/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDP.DE Biogen Inc.
144.80
-0.34%
GIS.DE Gilead Sciences, Inc.
87.37
+1.35%
6MK.DE Merck & Co., Inc.
97.70
+0.51%
BRM.DE Bristol-Myers Squibb Company
54.92
+0.02%
SNW.DE Sanofi
95.46
-0.89%
4AB.DE AbbVie Inc.
172.44
+0.44%
GS71.DE GSK plc
16.24
-0.18%
ZEG.DE AstraZeneca PLC
131.25
+0.04%
JNJ.DE Johnson & Johnson
139.68
+1.13%
AMG.DE Amgen Inc.
256.10
-0.02%